GLP1-S — Research Overview (RUO)

GLP1-S is a synthetic peptide research ligand structurally derived from human glucagon-like peptide-1 (GLP-1). It incorporates molecular modifications commonly used in experimental research to enhance stability and receptor interaction persistence under controlled laboratory conditions.

In research environments, GLP1-S is utilized as a reference compound for investigating GLP-1 receptor signaling behavior, intracellular pathway activation, and receptor-mediated metabolic signaling in non-clinical experimental models.

This material is supplied strictly as a chemical reference standard for laboratory research use only.

Compound Name
GLP1-S
Type
Synthetic GLP-1 Receptor Research Ligand
Primary Receptor Target
GLP-1 Receptor (GLP-1R)
Primary Research Context
Incretin receptor signaling and metabolic pathway research
Form
Lyophilized Powder
Chemical Formula
C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight
~4113.58 g/mol
Sequence Length
31 Amino Acids
Structural Modifications
Stability-oriented amino acid substitutions and lipid-associated modification commonly employed in receptor signaling research models.
Lipid conjugation is incorporated to support experimental investigation of prolonged receptor engagement and signaling persistence. Structural features are intended solely for laboratory research modeling and do not imply biological or therapeutic activity.
Store under conditions appropriate for laboratory reference compounds. Protect from moisture and light.
For laboratory research use only. Soluble in sterile bacteriostatic water consistent with established laboratory research protocols. Reconstituted material is not intended for long-term storage.
Sequence Length

GLP1-S is used in experimental research systems to study GLP-1 receptor activation patterns and downstream intracellular signaling cascades.

 

  • Receptor-ligand interaction dynamics

  • Signal transduction pathway mapping

  • Comparative incretin receptor activation studies

 

Experimental models examine how GLP-1 receptor signaling influences metabolic-associated cellular pathways under controlled laboratory conditions.

  • cAMP-mediated signaling

  • Cellular energy signaling markers

  • Transcriptional response profiling

GLP1-S is utilized in non-clinical research models to examine receptor-mediated signaling events in pancreatic islet systems.

  • Receptor-dependent insulin signaling pathways

  • Alpha- and beta-cell signaling dynamics

  • Intracellular response modulation

  • Model Dependence: Observed signaling effects vary by experimental system and assay design.

  • Species Variability: Receptor expression and signaling responses differ across laboratory models.

  • Non-Clinical Scope: Findings are limited to laboratory research contexts and are not predictive of clinical outcomes.

The following publications are provided solely for general scientific background related to GLP-1 receptor research and do not represent studies conducted using this specific material:

  • Lau, J., et al. (2015). Journal of Medicinal Chemistry

  • Knudsen, L. B., & Lau, J. (2019). Frontiers in Endocrinology

The compound listed below is referenced in research contexts related to the mechanisms discussed in this article.
GLP1-S is a chemical reference standard intended strictly for laboratory and in-vitro research applications. It is not a drug, dietary supplement, or medical product and is not intended for human or animal consumption, administration, diagnosis, or therapeutic use. All handling must be performed by qualified personnel in appropriate research environments.

GLP2-T

2023788-19-2

Thymosin Alpha-1 (TA1)

62304-98-7

Tesamorelin

218949-48-5

Selank

129954-34-3

GLP3-R

2381089-83-2

PT-141

189691-06-3